Hepatoblastoma is the most common type of liver cancer to occur in children. Approximately 100 new cases are diagnosed each year in the United States, accounting for 43% of all pediatric liver masses. Hepatoblastoma occurs most frequently in children under 3 years of age. It is more common in Caucasians than African- Americans, and occurs slightly more frequently in males than females.
Hepatoblastoma most frequently presents as a large, asymptomatic abdominal mass found by a physician on routine physical examination or discovered incidentally by a parent. As the disease progresses, weight loss, anorexia (loss of appetite), nausea, vomiting, fever, and abdominal pain may occur. Children with hepatoblastoma may develop anemia (pale skin and lips from decreased number of red blood cells) or jaundice (yellowing of the eyes and skin from elevated bilirubin).
Hepatoblastoma occurs much more frequently in patients with Beckwith-Wiedemann syndrome and familial adenomatous polyposis. Beckwith-Wiedemann syndrome is a condition characterized by the combination of a large tongue, large organs, large body size, umbical hernia, abdominal wall defects, and infantile low blood sugar. Familial adenomatous polyposis is an inherited disorder characterized by the presence of thousands of colon polyps which develop into colon cancer if untreated. Hepatoblastoma has also been shown to occur more frequently in premature children and those born with very low birth weight.
A tissue sample is taken from the primary tumor to confirm diagnosis.
Surgery and chemotherapy are the main treatment modalities for hepatoblastoma. As much as 85% of the liver can be safely removed during surgery because the remaining liver is able to regenerate itself within a few months. Any pulmonary metastases at the time of diagnosis should also be surgically removed if possible. Hepatoblastoma is very responsive to chemotherapy, so multiagent chemo regimens are initiated before surgery and continue after tumor resection. Liver transplantation has been shown to be a promising alternative for those children who have non-resectable tumors.
About 90% of children with respectable tumors achieve long-term survival. With tumors that can not be completely removed at diagnosis, survival rates drop to approximately 60%. When metastatic disease is present at the time of diagnosis, long- term survival occurs in only 25% of patients.
Herzog C. "Neoplasms of the Liver." In: Behrman ed: Nelson Textbook of Pediatrics 17th Edition. Saunders, 2004, pp1725-1726.
Mueller B, Lopez-Terrada D, Finegold M. "Tumors of the Liver." In : Pizzo and Poplack eds: Principles and Practice of Pediatric Oncology Fifth Edition. Philadelphia : Lippincott, Williams and Wilkins, 2006, pp885-904.
Passmore SJ, et al. "Prolonged survival following multiple thoracotomies for metastatic hepatoblastoma." Medical Pediatric Oncology 1995l 24:58-60.
Weinberg AG, Finegold MJ. "Primary hepatic tumors of childhood." Human Pathology 1983; 14:512-537
OncoLink is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through OncoLink should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem or have questions or concerns about the medication that you have been prescribed, you should consult your health care provider.
Information Provided By: www.oncolink.org | © 2016 Trustees of The University of Pennsylvania